๐Ÿ•ต๏ธ First Tracks Biotherapeutics, Inc. ($TRAX)

SEC insider & ownership activity, last 12 months ยท CIK 2091349 ยท every row links its SEC filing

Insider sell value was withheld pending verification over the last 12 months. No red-flag 8-Ks in the window.

Insider flow

0 buyers, $0 (0 lots) ยท 2 sellers, value withheld pending verification (2 lots)

InsiderBuysBoughtSellsSoldLast
Joe Anthony Ware0โ€“ 1$1.8MSep 2, 2026
ECOR1 Capital, LLC0โ€“ 1value withheld pending verificationApr 20, 2026

5%+ holders

HolderStakeClassScheduleEvent
ECOR1 Capital, LLC 9.1% 13GApr 22, 2026 filing โ†—
Oleg Nodelman 9.1% 13GApr 22, 2026 filing โ†—
ECOR1 Capital Fund Qualified, L.P. 8.5% 13GApr 22, 2026 filing โ†—
Chen Yu 8.3% 13GAug 14, 2026 filing โ†—
Sirenia Capital Management LP 7.2% 13GAug 14, 2026 filing โ†—
Alex Silverstein 7.2% 13GAug 14, 2026 filing โ†—
FMR LLC 5.9% 13GAug 6, 2026 filing โ†—
Abigail P. Johnson 5.9% 13GAug 6, 2026 filing โ†—
Affinity Asset Advisors, LLC 5.8% 13GAug 13, 2026 filing โ†—
Michael Cho 5.8% 13GAug 13, 2026 filing โ†—
BlackRock, Inc. 5.5% 13GJul 28, 2026 filing โ†—

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
Joe Anthony Ware$1.8MSep 2, 2026 filing โ†—

Material events (8-K)

ItemEvent date
Earnings (2.02)Aug 12, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Aug 12, 2026 filing โ†—
Material agreement (1.01)Jun 15, 2026 filing โ†—
Earnings (2.02)May 14, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 14, 2026 filing โ†—
Material agreement (1.01)Apr 20, 2026 filing โ†—
Acquisition or disposition (2.01)Apr 20, 2026 filing โ†—
Unregistered equity sale (3.02)Apr 20, 2026 filing โ†—
Material Modifications to Rights of Security Holders (3.03)Apr 20, 2026 filing โ†—
Change of control (5.01)Apr 20, 2026 filing โ†—
Officer/director changes (5.02)Apr 20, 2026 filing โ†—
Charter/bylaw changes (5.03)Apr 20, 2026 filing โ†—
Other events (8.01)Apr 20, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Apr 20, 2026 filing โ†—
Reg FD disclosure (7.01)Apr 1, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Apr 1, 2026 filing โ†—